The fossil record of early hominins in South Africa is biased towards periods of drier climate, suggests a study of cave deposits published online this week in Nature. This finding suggests there might be gaps in the fossil record, potentially obscuring evolutionary patterns and affecting our understanding of both the habitats and dietary behaviours of early hominins in this region.
South Africa’s highest concentration of early hominin fossils comes from caves northwest of Johannesburg, in the so-called ‘Cradle of Humankind’. However, it has proven difficult to precisely date these fossils and assess their evolutionary history, owing to the disordered nature of the collapsed cave sediments in which the remains were preserved.
Robyn Pickering and colleagues instead analysed the thick flowstones that surround the fossil-bearing sediments, which can be dated by measuring their trace radioactive isotopes. Flowstones, such as stalactites and stalagmites, form in caverns when flowing waters deposit dissolved minerals. The authors find that flowstones were deposited in six intervals between 3.2 and 1.3 million years ago. These, they suggest, represent wetter periods, in which there was more water to deposit the flowstones and the caves were more likely to be closed off to incoming sediments and hominin remains, allowing flowstones to form uninterrupted, but leaving gaps in the fossil record.
When the climate became drier, however, vegetation cover would have diminished, increasing surface erosion and opening the caves to outside sediments and the preservation of hominin remains. Although the wet periods may have left gaps in the fossil record, the authors note that the flowstones nevertheless offer valuable insights into past changes in the climate.
Zoology: Mineral armour discovered in insectsNature Communications
Neuroscience: Social isolation evokes craving responses in the human brainNature Neuroscience
Ecology: Migration associated with faster pace of lifeNature Communications
Gene therapy: Concerns for the long-term safety of AAV gene therapyNature Biotechnology